142 related articles for article (PubMed ID: 33465790)
21. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
22. [Uterine sarcomas: clinical and therapeutic aspects (10 cases)].
Hassini A; Khemiri B; Sfar E; Chelly D; Chennoufi MB; Chelly H
J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):348-55. PubMed ID: 16940904
[TBL] [Abstract][Full Text] [Related]
23. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
24. Multiple recurrences of early-stage, endometrioid-type G2 endometrial cancer with a long-time follow-up: A case study.
Semczuk A; Sagan D; Olcha P; Semczuk-Sikora A; Szumiło J; Pyra A; Rechberger T
Pathol Res Pract; 2015 Jun; 211(6):478-80. PubMed ID: 25701363
[TBL] [Abstract][Full Text] [Related]
25. Uterine papillary serous carcinoma. A clinical study.
Gitsch G; Friedlander ML; Wain GV; Hacker NF
Cancer; 1995 May; 75(9):2239-43. PubMed ID: 7712431
[TBL] [Abstract][Full Text] [Related]
26. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
[TBL] [Abstract][Full Text] [Related]
27. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
28. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
[TBL] [Abstract][Full Text] [Related]
29. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
30. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
32. Endometrioid carcinoma infiltrating atypical leiomyoma: a mimicker of malignant mixed Mullerian tumor.
Mahapatra QS; Ajay M; Kavita S
Indian J Pathol Microbiol; 2014; 57(2):317-9. PubMed ID: 24943777
[TBL] [Abstract][Full Text] [Related]
33. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
34. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB
Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726
[TBL] [Abstract][Full Text] [Related]
35. Uterine sarcoma.
Tanga R; Delgado G
Int Surg; 1982; 67(4):339-44. PubMed ID: 7160994
[TBL] [Abstract][Full Text] [Related]
36. [Malignant non-epithelial neoplasms of the uterine body--clinical analysis].
Emerich J; Konefka T; Dudziak M
Ginekol Pol; 1997 Dec; 68(12):610-4. PubMed ID: 9686471
[TBL] [Abstract][Full Text] [Related]
37. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract][Full Text] [Related]
38. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
39. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
40. Uterine sarcomas: review of 26 years at The Instituto Nacional de Cancerologia of Mexico.
Cantú de León D; González H; Pérez Montiel D; Coronel J; Pérez-Plasencia C; Villavicencio-Valencia V; Soto-Reyes E; Herrera LA
Int J Surg; 2013; 11(7):518-23. PubMed ID: 23664822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]